+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry



Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry



Acta Oncologica 55(11): 1378-1380




(PDF emailed within 0-6 h: $19.90)

Accession: 058654706

Download citation: RISBibTeXText

PMID: 27579554

DOI: 10.1080/0284186X.2016.1197422


Related references

Clinical Outcomes of Breast Proton Radiation Therapy: A Multi-institutional Analysis of the Proton Collaborative Group Registry. International Journal of Radiation Oncology*biology*physics 99(2): S213-S214, 2017

Clinical Outcomes of Patients with Stage II-III Non-Small Cell Lung Cancer (NSCLC) Treated with Proton Beam Therapy (PBT) on the Proton Collaborative Group (PCG) Prospective Registry Trial. International Journal of Radiation Oncology*biology*physics 96(2): E434-E435, 2016

Limited Toxicity After Proton Beam Therapy for Esophageal Cancer: Outcomes From the Proton Collaborative Group. International Journal of Radiation Oncology*biology*physics 96(2): E152-E153, 2016

Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial. Acta Oncologica: 1-7, 2017

Phase 2 Study of Consolidative Involved-Node Proton Therapy in Patients With Hodgkin Lymphoma: Early Outcomes. International Journal of Radiation Oncology*biology*physics 87(2): S162-S163, 2013

Low Levels of Acute Toxicity Associated With Proton Therapy for Low-Grade Glioma: A Proton Collaborative Group Study. International Journal of Radiation Oncology, Biology, Physics 96(2s): E135-E135, 2016

(P124) dosimetric comparison of three-dimensional conformal proton radiotherapy and intensity-modulated proton therapy for treatment of pediatric hodgkin lymphoma. Oncology 29(4 Suppl 1): -, 2015

Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study. International Journal of Radiation Oncology, Biology, Physics 89(5): 1053-1059, 2014

Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study. International Journal of Radiation Oncology, Biology, Physics 83(1): 260-267, 2012

EP-1404: Early results of proton beam therapy in sarcomas at the West German Proton Therapy Center Essen. RadioTherapy and Oncology 119: S654-S655, 2016

Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry. Catheterization and Cardiovascular Interventions, 2016

Proton therapy for Hodgkin lymphoma. Current Hematologic Malignancy Reports 9(3): 203-211, 2015

Patterns of care and survival outcomes examining radiation therapy for advanced Hodgkin lymphoma. Leukemia & Lymphoma 58(2): 343-347, 2016

Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: The impact of proton therapy and/or deep inspiration breath hold. RadioTherapy and Oncology 125(1): 41-47, 2017

Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors. Pediatric Blood & Cancer, 2018